The Application Value of Kuntujianzhong Therapy
Based on Theory of Visceral Manifestation in the Treatment of ICU-ENAD

doi:10.1009-0959.2025.120011

Abstract

Abstract:

Objective： To explore the application value of kuntujianzhong therapy based on theory of visceral manifestation in the treatment of enteral nutrition associated diarrhea （ENAD） in intensive care unit （ICU）.Methods： 120 patients with ENAD after enteral nutrition （EN） from ICU of our hospital were enrolled between July 2021 and June 2024. According to random number table method， the patients were divided into the observation group （n=60） and the control group （n=60）. On basis of routine EN treatment， the control group was treated with probiotic （live combined bacillus subtilis and enterococcus faecium enteric-coated capsules） combined with montmorillonite powder， while the observation group was treated with Kuntujianzhong therapy under the theory of Visceral Manifestation on basis of the control group for 5 d. The clinical curative effect in the two groups was observed. The scores of TCM syndromes， change of stool property （Hart diarrhea scale）， diarrhea degree （diarrhea degree scale）， diarrhea duration， nutritional indexes （serum albumin， prealbumin）， gastrointestinal quality of life index （GIQLI） and occurrence of incontinence-associated dermatitis were compared between the two groups before and after intervention.Results： After intervention， the reduction of scores of TCM syndromes （loose stool， pale complexion， limbs coldness）， Hart diarrhea scale and diarrhea degree in the observation group were greater than those in the control group （P<0.05）； diarrhea duration was shorter than that in the control group （P<0.05）； levels of serum albumin and prealbumin， and GIQLI score were higher than those in the control group （P<0.05）； total response rate was higher than that in the control group （96.67% vs. 80.00%， P<0.05）， and incidence of incontinence-associated dermatitis was lower than that in the control group （0.00% vs. 10.00%， P<0.05）.Conclusion： The application value of Kuntujianzhong therapy based on theory of Visceral Manifestation is good in ICU-ENAD patients， which can effectively regulate spleen-stomach function， improve clinical symptoms， shorten diarrhea duration， improve clinical curative effect， reduce incontinence-associated dermatitis and improve quality of life.

Key words: , Visceral manifestation； , Kuntujianzhong therapy； , Intensive care unit； , Enteral nutrition associated diarrhea

CLC Number:

R574.4

YANG Xiaofeng, HUANG Huayong, YANG Li, MING Zhouyan, LIU Zulu, LI Xiuqin.

The Application Value of Kuntujianzhong Therapy Based on Theory of Visceral Manifestation in the Treatment of ICU-ENAD [J]. CHINESE JOURNAL OF MEDICINAL GUIDE, 2025, 27(12): 1279-1279-1284.

References

［1］ Zhang D， Li H， Li Y， et al. Gut rest strategy and trophic feeding in the acute phase of critical illness with acute gastrointestinal injury［J］.Nutr Res Rev， 2019，32（2）：176-182.

［2］ Fabiani A， Sanson G， Bottigliengo D，et al. Impact of a natural versus commercial enteral-feeding on the occurrence of diarrhea in critically ill cardiac surgery patients：a retrospective cohort study［J］.Int J Nurs Stud， 2020，108：103605.

［3］祝武辉，冷朝霞.ICU患者肠内营养期间腹泻的相关因素分析［J］.现代消化及介入诊疗，2019，24（A02）：2634.

［4］谢赟，郑娉娉，江哲龙，等.重症患者早期肠内营养发生腹泻的相关因素分析：一项多中心横断面调查［J］.中国中西医结合急救杂志，2019，26（4）：459-462.

［5］侯晓红，孙倩，孟珠，等.基于指南的集束化方案在预防ICU患者肠内营养并发腹泻的效果研究［J］.中国实用护理杂志，2022，38（25）：1927-1932.

［6］王瑶，于玲，曹文文.莫沙必利联合多潘立酮对肠内营养期结直肠癌患者胃肠功能的影响［J］. 现代消化及介入诊疗，2019，24（4）：347-351.

［7］李刚，张良田，张可，等.蕊福平治疗重症患者使用肠内营养引起的腹泻临床疗效［J］.广东医学，2019，40（20）：2862-2866.

［8］吴群强，焦卉朵，廖春华.可溶性膳食纤维联合益生菌在老年患者肠内营养相关性腹泻中的应用［J］.贵州医药，2019，43（3）：432-434.

［9］冯文林，伍海涛.从肠道菌群探讨多种疾病从脾论治的机理［J］.吉林中医药，2018，38（10）：1124-1127.

［10］陈智慧，张哲，裴宇鹏，等.中医脾藏象理论的研究方法探讨［J］.中华中医药杂志，2020，35（6）：2700-2702.

［11］谢胜，刘园园，彭柳莹，等.基于藏象理论坤土建中疗法的理论构建及其应用探索［J］.辽宁中医杂志，2016，43（1）：13-15.

［12］廉永红，谢胜，刘祖露，等.坤土建中法治疗虚寒型胃脘痛的临床研究［J］.中医药导报，2019，25（13）：66-68.

［13］杨小凤，阳莉，李秀琴，等.坤土建中疗法在ICU抗生素腹泻患者的应用［J］. 世界最新医学信息文摘（连续型电子期刊），2020，20（A2）：111-112.

［14］国家中医药管理局.中医病证诊断疗效标准［M］.南京：南京大学出版社，1994：289-290.

［15］罗旭娟.早期鼻胃管肠内营养对重症急性胰腺炎临床疗效研究［D］.西南医科大学，2015.

［16］张奕颖，陈瑞华.参苓白术散联合脐贴治疗ICU肠内营养相关性腹泻患者的临床观察［J］.中国现代医生，2018，56（30）：139-141.

［17］王轶，朱生樑.非糜烂性反流病患者生活质量评价［J］.广东医学，2018，39（3）：438-442.

［18］ van Zanten ARH， De Waele E， Wischmeyer PE. Nutrition therapy and critical illness： practical guidance for the ICU， post-ICU， and long-term convalescence phases［J］.Crit Care， 2019，23（1）：368.

［19］ Yang G， Zheng B， Yu Y. Risk assessment of intermittent and continuous nasogastric enteral feeding methods in adult inpatients：a Meta-analysis［J］.Evid Based Complement Alternat Med， 2021，7：8875002.

［20］陈俊仙，陈彩，杜瑾，等.子午流注穴位按摩联合果胶治疗肠内营养相关性腹泻临床研究［J］.新中医，2021，53（16）：147-150.

［21］叶溪茜，石占利，杨政，等.健脾消食贴联合红外线照射对ICU肠内营养AECOPD患者胃肠道并发症的防治效果及对胃肠激素的影响［J］.中国中医药科技，2023，30（2）：261-264.

［22］王海翔，严锋，缪卫红，等.参苓白术散治疗老年肠内营养相关腹泻［J］. 长春中医药大学学报，2017，33（3）：434-436.

［23］吴静洁，梅应兵，甘爱萍，等.益气健脾中药复方治疗肠内营养相关性腹泻Meta分析［J］.湖北中医杂志，2020，42（4）：57-60.

［24］戴益慧，唐娅琴.砭石隔药灸治疗中风患者肠内营养相关性腹泻的临床观察［J］.中国中医药科技，2022，29（5）：797-799.

［25］朱媛媛，樊威伟，何亚鑫.四神丸合补中益气汤治疗慢性腹泻的临床疗效观察［J］.天津中医药，2023，40（2）：155-158.

［26］潘丹峰，苍玉珍，沈峰，等.健脾法联合肠内营养对溃疡性结肠炎大鼠肠道菌群的影响［J］.新医学，2020，51（9）：691-696.

［27］杨志华，邓柳颐，李冬梅，等.中药复方对肠道微生态调节作用的研究［J］.西部中医药，2020，33（9）：166-168.

［28］刘燕，张文娴，吴耀松，等.中医肺脾肾三脏与机体免疫调节的关系［J］.中国中西医结合急救杂志，2022，29（1）：119-122.

[1]	WANG Caixue, SUN Ting, LI Xuan, SHAN Bin, WEN Tianjiao, WANG Mingxia. Analysis of Development Status and Challenges of Drug Clinical Trial Tnstitution in Hebei Province [J]. CHINESE JOURNAL OF MEDICINAL GUIDE, 2025, 27(9): 995-1000.
[2]	JIAO Jian, XU Liang, YANG Lingyan. The Construction of A “Dual-Practice” Training Model for Inter-Disciplinary TCM Management Talents in Hospitals under the Background of "New Medicine" [J]. CHINESE JOURNAL OF MEDICINAL GUIDE, 2025, 27(9): 967-973.
[3]	CAO Jie, TIAN Neng, WANG Huan. The Application of Cupping Therapy in Common Pediatric Diseases [J]. CHINESE JOURNAL OF MEDICINAL GUIDE, 2025, 27(9): 902-906.
[4]	WANG Xiaolan, XIE Guifang, JIANG Yan, Zhang Xiaoqian, REN Kun. Study on Migration of Styrene from Disposable Intravenous Indwelling Needle in 5 Kinds of Liquid Medicine [J]. CHINESE JOURNAL OF MEDICINAL GUIDE, 2025, 27(9): 954-959.
[5]	ZHU Xiaoyue, ZHANG Zhe, SUN Yi, AN Jingye, ZHENG Jie, WU Zhaowei. Improvement of Determination Method about Vitamin D₃ Assay in Standards for Calcium Carbonate and Vitamin D₃ Preparations [J]. CHINESE JOURNAL OF MEDICINAL GUIDE, 2025, 27(9): 950-953.
[6]	KONG Weisong, CAO Dengyan, SHI Xuemin, XUE Ya, JIA Tingting, QIAN Fengdan, XU Yanfeng, ZHANG Lichao. Comparative Analysis of Requirements on Medical Institutions from Management Rules for Traditional Chinese Medicine Formula Granules among Provinces [J]. CHINESE JOURNAL OF MEDICINAL GUIDE, 2025, 27(9): 960-966.
[7]	XIE Qing, GUO Qing, MIAO Lili. Relationship between the Risk of MACE during the Vulnerable Phase and Relevant Test Indexes in Patients with Acute Heart Failure [J]. CHINESE JOURNAL OF MEDICINAL GUIDE, 2025, 27(9): 907-911.
[8]	LI Jihong, CHEN Jing, NIAN Honglei, WANG Xinghe. Exploration of the Full Chain Protection Strategy for the Rights and Interests of Participants in Clinical Research of Cell Therapy [J]. CHINESE JOURNAL OF MEDICINAL GUIDE, 2025, 27(9): 987-994.
[9]	YIN Yanli, XU Renen. Application and Thinking of Remote Monitoring in Drug Regulation [J]. CHINESE JOURNAL OF MEDICINAL GUIDE, 2025, 27(9): 878-881.
[10]	ZUO Yangbin, LI Jin, LIN Tianyu, WU Lijuan, CHEN Chunxi. Epidemiological Characteristics of Multi-Drug Resistant Mycobacterium Tuberculosis and Analysis of Factors Affecting Patient Treatment Adherence [J]. CHINESE JOURNAL OF MEDICINAL GUIDE, 2025, 27(9): 982-986.
[11]	CHEN Wenping, WANG Guangping, ZHANG Ji. Hospital Pharmacovigilance System Based on Management Model of External Prescription Dispensing [J]. CHINESE JOURNAL OF MEDICINAL GUIDE, 2025, 27(9): 882-888.
[12]	BIAN Xiaoyue, LIANG Yaxing, YIN Chen, YANG Xueying, WANG Hongying, ZHAO Yurong. Research Progress on 3D Printing Materials and 3D Printing Technology for Cranioplasty [J]. CHINESE JOURNAL OF MEDICINAL GUIDE, 2025, 27(9): 889-895.
[13]	FU Jiyou, SHANG Qinghui, JIANG Lin, MAO Xiao, LI Yang. Research Progress on the Efficacy， Indications， Clinical Applications， and Modern Pharmacological Effects of Baibu [J]. CHINESE JOURNAL OF MEDICINAL GUIDE, 2025, 27(9): 896-901.
[14]	LIU Chunyu, YANG Wanjun, WEI Namin, ZHANGnan , ZHAI Huaqiang, JIN Shiyuan. Bibliometrics Research on Traditional Chinese Medicine in the Treatment of Lung Cancer in Recent 10 Years [J]. CHINESE JOURNAL OF MEDICINAL GUIDE, 2025, 27(9): 930-939.
[15]	LIU Zhihui, LU Meijing, YIN Li, YANG Yuanyuan, WANG Jiaxin, WANG Shigong. Study on the Characteristics and Meteorological Triggers of Circulatory System Diseases in Panzhihua Based on Machine Learning [J]. CHINESE JOURNAL OF MEDICINAL GUIDE, 2025, 27(9): 974-981.

The Application Value of Kuntujianzhong Therapy Based on Theory of Visceral Manifestation in the Treatment of ICU-ENAD

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments